Not applicableStudy completedNCT02175693
What this trial is testing
Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
Who this might be right for
Cervical Dystonia
Eisai Co., Ltd. 1,647